Hyperprolactinemia and Impotence: Why, when and how to Investigate
- 1 October 1989
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 142 (4) , 992-994
- https://doi.org/10.1016/s0022-5347(17)38964-4
Abstract
The contribution of hyperprolactinemia to erectile disorders has not been clarified. Modest elevations of serum prolactin occur after administration of drugs that by themselves affect erectile function. Prolactinomas produce marked elevations of the hormone and invariably are accompanied by hypogonadotropic hypogonadism. Among 1,236 consecutive impotent patients investigated at our center 5.3% had serum levels of prolactin greater than normal. Only 34 of the 66 hyperprolactinemic patients were available for analysis. The etiology of the hyperprolactinemia in this group was pituitary adenoma in 14.7%, drug-induced in 29%, chronic renal failure in 6%, laboratory error in 2.9% and idiopathic in 47.1%. Medical management has a high degree of success but simply lowering the levels of prolactin is not invariably accompanied by restoration of function.This publication has 11 references indexed in Scilit:
- Hormonal Effects of Smoking—I: Effects on Plasma Renin ActivityThe Lancet Healthy Longevity, 1986
- Endocrine Dysfunction in Impotence: Incidence, Significance and Cost-Effective ScreeningJournal of Urology, 1984
- Evaluation of the Urological Assessment in Impotence: Findings with a New Diagnostic Rating ScaleJournal of Urology, 1984
- Psychogenic impotence: New light on its causationWorld Journal of Urology, 1983
- Neuroendocrinology and ImpotenceAnnals of Internal Medicine, 1983
- Corporeal Calibration: A Discriminatory test for ImpotenceJournal of Urology, 1982
- Prolactin and Sexual FunctionJAMA, 1980
- Serum Prolactin in Organic and Psychogenic ImpotenceJournal of Urology, 1980
- HYPERPROLACTINAEMIA AND HYPOGONADISM IN MEN: RESPONSE TO EXOGENOUS GONADOTROPHINSClinical Endocrinology, 1979